SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise

Nothing in Abbott Laboratories (NYSE: ABT ) ‘s trading history since 1968 resembles Thursday morning. A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever recorded. Shares of Abbott Laboratories jumped as much as 13.6% by 9:00 a.m. ET. What Happened: The company reported second-quarter adjusted earnings of $1.31 per share, above the $1.28 consensus. Sales rose 13% to $12.59 billion, topping estimates near $12.5 billion. Comparable sales — which strip out currency swings and the Exact Sciences acquisition — grew 4.8%. Abbott lifted its full-year adjusted earnings guidance to $5.45 to $5.60 per share, from $5.38 to $5.58, and reaffirmed comparable sales growth of 6.5% to 7.5%. “Our second-quarter results reflect the momentum we are building,” said Robert B. Ford, chairman and chief executive officer. Why it m...

ABT

Nothing in Abbott Laboratories (NYSE: ABT ) ‘s trading history since 1968 resembles Thursday morning. A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever recorded. m. ET.

28 consensus. 5 billion. 8%. 5%.

“Our second-quarter results reflect the momentum we are building,” said Robert B. Ford, chairman and chief executive officer. Why it matters: the bar was on the floor. 97, their weakest since April 2020.

16.